These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 828359)

  • 1. [Specific desensitization of pollinosis by various allergen extracts (author's transl)].
    Schuchardt P; Hühnerfuss S
    Z Erkr Atmungsorgane; 1976 Aug; 146(2):115-9. PubMed ID: 828359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pollinosis. II. Specific hyposensitization: indications and results of treatment. A study with the allergen preparation Stallergenes-Depot in the pollen season of 1976, 1977 and 1978].
    Wüthrich B; Häfner G
    Schweiz Med Wochenschr; 1980 Feb; 110(8):281-90. PubMed ID: 7367848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long term follow up after parenteral specific hyposensitization in children (author's transl)].
    Urbanek R; Karitzky D
    Klin Padiatr; 1975 Nov; 187(6):513-7. PubMed ID: 1240550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reduced allergen immunotherapy of grass pollinosis (author's transl)].
    Horak F; Jäger S; Skoda-Türk R
    Wien Klin Wochenschr Suppl; 1980; 117():36-8. PubMed ID: 6936982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Late results of hyposensitization therapy of pollinosis. Follow-up studies of 328 cases 2-5 years after termination of injection treatment with aqueous or semi-depot allergen extracts].
    Wüthrich B; Günthard HP
    Schweiz Med Wochenschr; 1974 May; 104(20):713-7. PubMed ID: 4829628
    [No Abstract]   [Full Text] [Related]  

  • 6. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
    Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
    J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A modified therapy of hayfever with a depot-preparation (author's transl)].
    Skoda-Türk R; Horak F; Jäger S
    Wien Klin Wochenschr Suppl; 1980; 117():24-6. PubMed ID: 6936978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiallergen immunotherapy for allergic rhinitis and asthma.
    Nelson HS
    J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management in pollinosis and false pollinosis].
    Tabart J; Gallois JR; Marland P; Fleury P
    Ann Otolaryngol Chir Cervicofac; 1978 Dec; 95(12):733-46. PubMed ID: 36022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hyposensitization in pollinosis. Results of a 3-year controlled study with 2 depot-allergoid grass pollen extracts: aluminum hydroxide-adsorbed allergoid and tyrosine-adsorbed allergoid].
    Mühlethaler K; Wüthrich B; Peeters AG; Terki N; Girard JP; Frank E
    Schweiz Rundsch Med Prax; 1990 Apr; 79(14):430-6. PubMed ID: 2188335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epicutaneous allergen administration: a novel approach for allergen-specific immunotherapy?
    Werfel T
    J Allergy Clin Immunol; 2009 Nov; 124(5):1003-4. PubMed ID: 19895988
    [No Abstract]   [Full Text] [Related]  

  • 12. Sublingual immunotherapy for Japanese cedar pollinosis.
    Okubo K; Gotoh M
    Allergol Int; 2009 Jun; 58(2):149-54. PubMed ID: 19390236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Side-effects of injective allergen immunotherapy administered to intermittent or persistent allergic rhinitis patients.
    Rogala B; Markiewicz-Bendkowska IB; Brzoza Z; Glück J; Oleś E
    Rhinology; 2007 Jun; 45(2):134-9. PubMed ID: 17708460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A clinical evaluation of methods fpr specific hyposensitization in pollinosis].
    Bulakhova EK
    Vrach Delo; 1991 Mar; (3):63-5. PubMed ID: 2042353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis.
    Frew AJ; Powell RJ; Corrigan CJ; Durham SR;
    J Allergy Clin Immunol; 2006 Feb; 117(2):319-25. PubMed ID: 16461133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sublingual immunotherapy].
    Nelken D
    Harefuah; 1996 Sep; 131(5-6):164-5, 215. PubMed ID: 8940498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study of the effectiveness of 2 methods of specific immunotherapy of pollinoses].
    Polsacheva OV; Gushchin IS; Poroshina IuA; Chitaeva VG; Shustova VI
    Ter Arkh; 1986; 58(4):120-3. PubMed ID: 2424113
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunotherapy of pollinosis: results of a 2-year study with a new allergen preparation (novo-helisen depot) (author's transl)].
    Wüthrich B
    Schweiz Rundsch Med Prax; 1977 Mar; 66(9):260-6. PubMed ID: 840831
    [No Abstract]   [Full Text] [Related]  

  • 19. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
    Panzner P; Petrás M; Sýkora T; Lesná I
    Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential rates of allergen release: an important consideration in the preparation of allergenic extracts.
    Marsh DG
    Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1987; (80):47-57. PubMed ID: 3688873
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.